InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Biobillionair post# 28157

Monday, 05/26/2014 3:07:15 AM

Monday, May 26, 2014 3:07:15 AM

Post# of 429476
Biobill,

I do not say it's impossible, however why do you think that the event rate (design 5,2% in placebo group) will be lower? Why not higher, since they increased the min. TG from 150 to 200?

Why you called the solution as miracle? If we think - and yes we think - that the background of ANCHOR SPA & sNDA is valid, it's not a miracle. Don't misunderstand me (it's not an attack), but if we need a miracle what's the use of your CP?

They could fund the R-IT till interim result, if - and you have right regarding this - the gross profit (higher revenue lower COGS) will be significantly higher. (They need - with 65% GM - 25k scripts / week to reach +/-0 OIL - it's not unbelievable. I know it's not so simple, but let's play w numbers: 130 rep deliver 3,351 NRx, so the additional 250 will deliver 6,444 Nrx total: 9,795. If the refill will reach the 'standard' 1:2 ratio - nRx:Refill - that will add 19,590 resulted in 29,386 TRx)

We could see some sign in July / August as the earliest - what's the trend of scripts?, what's delivered by KOWA?

We need ANCHOR approval - and I think it's not a miracle, just not easy - however w/o ANCHOR we could survive, but w/o higher GP we could not, so the most important thing is not ANCHOR, but scripts.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News